Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Dev Ctries ; 18(5): 726-731, 2024 May 30.
Article in English | MEDLINE | ID: mdl-38865389

ABSTRACT

INTRODUCTION: Serratia marcescens is an opportunistic pathogen found ubiquitously in the environment and associated with a wide range of nosocomial infections. This multidrug-resistant bacterium has been a cause of concern for hospitals and healthcare facilities due to its ability to spread rapidly and cause outbreaks. Next generation sequencing genotyping of bacterial isolates has proven to be a valuable tool for tracking the spread and transmission of nosocomial infections. This has allowed for the identification of outbreaks and transmission chains, as well as determining whether cases are due to endogenous or exogenous sources. Evidence of nosocomial transmission has been gathered through genotyping methods. The aim of this study was to investigate the genetic diversity of carbapenemase-producing S. marcescens in an outbreak at a public hospital in Cuiaba, MT, Brazil. METHODOLOGY: Ten isolates of S. marcenses were sequenced and antibiotic resistance profiles analyzed over 12 days. RESULTS: The isolates were clonal and multidrug resistant. Gentamycin and tigecycline had sensitivity in 90% and 80% isolates, respectively. Genomic analysis identified several genes that encode ß-lactamases, aminoglycoside-modifying enzymes, efflux pumps, and other virulence factors. CONCLUSIONS: Systematic surveillance is crucial in monitoring the evolution of S. marcescens genotypes, as it can lead to early detection and prevention of outbreaks.


Subject(s)
Anti-Bacterial Agents , Cross Infection , Disease Outbreaks , Drug Resistance, Multiple, Bacterial , Intensive Care Units , Serratia Infections , Serratia marcescens , Whole Genome Sequencing , Serratia marcescens/genetics , Serratia marcescens/drug effects , Serratia marcescens/isolation & purification , Humans , Brazil/epidemiology , Drug Resistance, Multiple, Bacterial/genetics , Serratia Infections/microbiology , Serratia Infections/epidemiology , Cross Infection/microbiology , Cross Infection/epidemiology , Anti-Bacterial Agents/pharmacology , Microbial Sensitivity Tests , Genotype , Genome, Bacterial , beta-Lactamases/genetics , Genetic Variation
SELECTION OF CITATIONS
SEARCH DETAIL
...